Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Fjellbirkeland

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The European Respiratory Journal|November 7, 2015
Lung cancer survival in Norway, 1997-2011: from nihilism to optimismYngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutationsMarius Lund-Iversen, Lilach Kleinberg, Lars Fjellbirkeland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
Lung Cancer in NorwayOdd Terje Brustugun, Bjørn Henning Grønberg, Marianne Aanerud, et al.
Cancer Treatment and Research Communications|October 26, 2021
Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancerDan Laerum, Odd Terje Brustugun, Frode Gallefoss, et al.
Cancer Treatment and Research Communications|February 7, 2020
Reduced delays in diagnostic pathways for non-small cell lung cancer after local and National initiativesDan Laerum, Odd Terje Brustugun, Frode Gallefoss, et al.
British Journal of Cancer|November 3, 2024
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort studyHelga H Hektoen, Kaitlyn M Tsuruda, Lars Fjellbirkeland, et al.
BMC Pulmonary Medicine|March 4, 2024
Distribution and characteristics of malignant tumours by lung lobeYngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2024
Evaluation of sex inequity in lung-cancer-specific survivalDan Lærum, Trond-Eirik Strand, Odd Terje Brustugun, et al.
The American Journal of Pathology|July 24, 2003
Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissueLars Fjellbirkeland, Stephanie Cambier, V Courtney Broaddus, et al.
International Journal of Cancer|October 1, 2015
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverageYngvar Nilssen, Trond-Eirik Strand, Lars Fjellbirkeland, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The European Respiratory Journal|November 7, 2015
Lung cancer survival in Norway, 1997-2011: from nihilism to optimismYngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutationsMarius Lund-Iversen, Lilach Kleinberg, Lars Fjellbirkeland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
Lung Cancer in NorwayOdd Terje Brustugun, Bjørn Henning Grønberg, Marianne Aanerud, et al.
Cancer Treatment and Research Communications|October 26, 2021
Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancerDan Laerum, Odd Terje Brustugun, Frode Gallefoss, et al.
Cancer Treatment and Research Communications|February 7, 2020
Reduced delays in diagnostic pathways for non-small cell lung cancer after local and National initiativesDan Laerum, Odd Terje Brustugun, Frode Gallefoss, et al.
British Journal of Cancer|November 3, 2024
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort studyHelga H Hektoen, Kaitlyn M Tsuruda, Lars Fjellbirkeland, et al.
BMC Pulmonary Medicine|March 4, 2024
Distribution and characteristics of malignant tumours by lung lobeYngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2024
Evaluation of sex inequity in lung-cancer-specific survivalDan Lærum, Trond-Eirik Strand, Odd Terje Brustugun, et al.
The American Journal of Pathology|July 24, 2003
Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissueLars Fjellbirkeland, Stephanie Cambier, V Courtney Broaddus, et al.
International Journal of Cancer|October 1, 2015
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverageYngvar Nilssen, Trond-Eirik Strand, Lars Fjellbirkeland, et al.
Pageof 3